ISSN: 2278-0238

Revue internationale de recherche et développement en pharmacie et sciences de la vie

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Novel Approaches for Treatment of Colorectal Cancer- An Overview

Pramita Waghambare, Prabha Singh, Pramila Chaubey*

Colorectal cancer (CRC) is considered as the third most common cancer and the fourth foremost cause of death worldwide. Various
attempts have been made to diagnose and treat CRC. However, the incidence and mortality rates are still high. For CRC, currently available
chemotherapy delivers the drugs usually to both cancerous as well as normal cells, hence resulting in various undesirable side effects.
Therefore, nowadays more emphasis is been given on targeted drug delivery systems as it directly reaches to site of action with minimal
unwanted side effects. This review focuses on novel approaches for the treatment of CRC. Plant-derived drugs shows promising anticancer
activity and have various advantages over chemotherapeutics agents have also been explored. The current paper also elaborates on
synthetic drugs, plant-derived drugs and drugs targeting to overexpressed proteins in CRC including recent clinical trials in combinations
with other chemotherapeutics for the treatment of CRC.